ResearcherMiyagi Prefectural Hospital OrganizationActive in the last 2 years
Hiroyuki Kato
Matched on ORCID iD 0000-0002-5888-6217; OpenAlex author ID A5080903282. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 4
- The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer. Co-author DOI 10.1002/cam4.70124↗
- PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. Co-author DOI 10.1111/cas.15315↗
- DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer. Co-author DOI 10.1093/carcin/bgab017↗
- Case of pancreatic metastasis from colon cancer in which cell block using the Trefle® endoscopic scraper enables differential diagnosis from pancreatic cancer. Co-author DOI 10.4251/wjgo.v10.i3.91↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Akihisa Kato · 3 shared papers, 2018–2024 · strength 0.39
- Paper The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer. DOI 10.1002/cam4.70124↗
- Paper DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer. DOI 10.1093/carcin/bgab017↗
- Paper Case of pancreatic metastasis from colon cancer in which cell block using the Trefle® endoscopic scraper enables differ… DOI 10.4251/wjgo.v10.i3.91↗
- Satoru Takahashi · 3 shared papers, 2018–2024 · strength 0.39
- Paper The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer. DOI 10.1002/cam4.70124↗
- Paper DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer. DOI 10.1093/carcin/bgab017↗
- Paper Case of pancreatic metastasis from colon cancer in which cell block using the Trefle® endoscopic scraper enables differ… DOI 10.4251/wjgo.v10.i3.91↗
- Shingo Inaguma · 2 shared papers, 2021–2024 · strength 0.32
- Yoichi Matsuo · 2 shared papers, 2021–2024 · strength 0.32
- Makoto Sano · 1 shared paper, 2024 · strength 0.20
- Hideaki Ijichi · 1 shared paper, 2024 · strength 0.20
- Kenta Kachi · 1 shared paper, 2021 · strength 0.12
- Ikuro Sato · 1 shared paper, 2022 · strength 0.12
- Keiichi Jingu · 1 shared paper, 2022 · strength 0.12
- Keiichi Tamai · 1 shared paper, 2022 · strength 0.12
- Katsuya Fukui · 1 shared paper, 2022 · strength 0.12
- Hiroshi Shima · 1 shared paper, 2022 · strength 0.12
- Kennichi Satoh · 1 shared paper, 2022 · strength 0.12
- Toru Furukawa · 1 shared paper, 2022 · strength 0.12
- Itaru Naitoh · 1 shared paper, 2018 · strength 0.07
- Yasuki Hori · 1 shared paper, 2018 · strength 0.07
- Shuji Takiguchi · 1 shared paper, 2018 · strength 0.07
- Naruomi Jinno · 1 shared paper, 2018 · strength 0.07
- Takashi Joh · 1 shared paper, 2018 · strength 0.07
- Michihiro Yoshida · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.